Australian Health Minister Warns Illegal E-cigarette Sellers: Find Alternative Revenue Methods

Regulations by 2FIRSTS.ai
Jan.12.2024
Australian Health Minister Warns Illegal E-cigarette Sellers: Find Alternative Revenue Methods
Australian Health Minister, Mark Butler, warns businesses selling illegal e-cigarettes to find other sources of profit.

According to a report from the Daily Mail, Australian Health Minister Mark Butler has issued a warning to retailers who sell illegal e-cigarettes on the market that they will have to find alternative means of making a profit. He has also dismissed the idea of regulating e-cigarettes in a similar manner to tobacco and alcohol.

 

This warning was issued after the Australian Daily Mail demonstrated the ease of purchasing such prohibited devices, despite Butler implementing an import ban on disposable e-cigarettes on January 1st this year.

 

As you walk along Sydney's bustling Golden Street in the city center, you will find at least 20 independent and chain stores selling illegal nicotine e-cigarettes, illicit cigarettes, and other related devices. Purchasing an e-cigarette is as effortless as buying a can of soda or a newspaper, often without the need for identification verification. The average price for one e-cigarette is approximately 25 Australian dollars.

 

Minister Butler informed the Daily Mail Australia that the government will not turn a blind eye to this situation's unfolding. He has instructed businesses in this trade sector to explore alternative avenues for profitability.

 

E-cigarette stores intentionally setting up near schools is an apparent targeting of children by the industry.

 

In 2021, in accordance with regulations introduced by the previous Morrison government, the sale of e-cigarettes containing nicotine has been deemed illegal. However, many retailers continue to openly sell these products in illegal ways, with some even incorrectly labeling them as nicotine-free. To address the loopholes in the previous legislation and crack down on the supply of e-cigarettes in convenience stores, Minister Butler implemented a nationwide ban on the importation of disposable e-cigarettes on January 1st. Retailers can still sell existing stock imported prior to January 1st, as long as it is nicotine-free.

 

Changes in the draft design include the establishment of a new access method that allows doctors and nurses to prescribe therapeutic e-cigarettes for smokers or individuals in need of nicotine dependency control.

 

However, former federal police officer Rohan Pike has stated that enforcing the import ban on disposable e-cigarettes will prove challenging for the Australian Border Force (ABF), and the black market will continue to thrive.

 

Criminal gangs are importing e-cigarettes from China and selling them to retailers, thus boosting their profit margins.

 

Over 90% of e-cigarettes sold in Australia are black-market products.

 

Brian Marlow, the director of the Australian legal e-cigarette lobbying group, has stated that the import ban simply allows retailers to charge consumers higher prices due to the risks associated with importing and selling these products. He suggests that market restrictions, the establishment of product standards, granting licenses to retailers, and imposing heavy penalties for selling to minors will help eliminate the black market.

 

Australia should follow the examples of New Zealand, the UK, and other countries worldwide in implementing regulations for e-cigarettes," he said. "We should allow the sale of high-quality e-cigarettes and regulate them in a similar manner as we do with adult-restricted products such as alcohol.

 

Achieving this would enable adults to access products that are safer than the disposable ones commonly found in China, without being burdened by exorbitant levels of nicotine.

 

In response to Marlo's suggestion, Minister Butler responded, "The only groups that would benefit from regulating and selling e-cigarettes are those who profit from children becoming addicted to nicotine - big tobacco companies and tobacco retailers.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Juul Labs UK has introduced an upgraded JUUL2 Starter Kit for the UK market in October 2026, retaining a recommended retail price of £9.99 while doubling the number of included pods from two to four. The kit contains Crisp Menthol, Virginia Tobacco, Mango and Watermelon pods. The updated device replaces the previous proprietary charging dock with a USB-C port and offers longer battery life. The kit also features reduced packaging and retains a two-year limited warranty. Distribution is scheduled through major UK retailers, wholesalers, convenience stores and the JUUL UK website.
product
Oct.15
Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Japan Tobacco Inc. (JT) announced on November 12, 2026, that it had acquired the U.S. assets of nicotine pouch brand CLEW from Nevcore Innovations Inc., including trademarks, intellectual property, product formulations and a Premarket Tobacco Product Application (PMTA). CLEW, currently distributed through selected outlets in 13 U.S. states, will immediately join the JTI LIGGETT portfolio. The transaction follows JT's approximately $2.4 billion acquisition of U.S. cigarette maker Vector Group in 2024. JTI LIGGETT says its existing cigarette brands reach more than 160,000 U.S. retail stores. During the 2026 NACS Show in October, JTI LIGGETT booth staff told 2Firsts that the company had not yet launched nicotine pouches in the United States. Although Nevcore previously announced FDA acceptance of CLEW's PMTA, the brand is absent from the agency's current list of authorized nicotine pouch products. JT has not disclosed a retail expansion plan for CLEW.
Business
Nov.12
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09